Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB12003 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB12003, RRID:AB_1715549
- Product name
- Tdgf1 polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against synthetic peptide of Tdgf1.
- Storage
- Store at 4°C. Do not freeze.
Submitted references Cripto: a novel target for antibody-based cancer immunotherapy.
Cripto: a tumor growth factor and more.
Fucosylation of Cripto is required for its ability to facilitate nodal signaling.
Xing PX, Hu XF, Pietersz GA, Hosick HL, McKenzie IF
Cancer research 2004 Jun 1;64(11):4018-23
Cancer research 2004 Jun 1;64(11):4018-23
Cripto: a tumor growth factor and more.
Adamson ED, Minchiotti G, Salomon DS
Journal of cellular physiology 2002 Mar;190(3):267-78
Journal of cellular physiology 2002 Mar;190(3):267-78
Fucosylation of Cripto is required for its ability to facilitate nodal signaling.
Schiffer SG, Foley S, Kaffashan A, Hronowski X, Zichittella AE, Yeo CY, Miatkowski K, Adkins HB, Damon B, Whitman M, Salomon D, Sanicola M, Williams KP
The Journal of biological chemistry 2001 Oct 12;276(41):37769-78
The Journal of biological chemistry 2001 Oct 12;276(41):37769-78
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western blot analysis of Tdgf1 in 20 ug of MDA-MB-21 lysate with Tdgf1 polyclonal antibody (Cat # PAB12003).
